OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(42 intermediate revisions by 5 users not shown)
Line 17: Line 17:
:follow the instructions for subscribing  
:follow the instructions for subscribing  


*We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
*We meet in Mac Hall 2201
:Fridays 9:15-10:15 AM - see schedule below
:Fridays 9:00-10:15 AM - see schedule below
:Breakfast provided by the Knight!
:Breakfast provided by the Knight!
*Organizer: Rosie Sears, email searsrATohsu.edu
*Organizer: Rosie Sears, email searsrATohsu.edu
Line 42: Line 42:
[http://www.ohsu.edu/academic/som/ngp/faculty-profile.cfm?facultyID=346 Spindel Lab], Primate Center, NGP, Cancer Biology
[http://www.ohsu.edu/academic/som/ngp/faculty-profile.cfm?facultyID=346 Spindel Lab], Primate Center, NGP, Cancer Biology


[http://omlc.ogi.edu Jacques Lab], Biomedical Engineering/Dermatology
[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biomedical-engineering/people/joe-gray.cfm Gray Lab], OHSU Center for Spacial Systems Biology
*Add your lab here
*Add your lab here


Line 57: Line 60:


|--
|--
| 9/23/2011
| 9/21/2012
|Thomas Jacob
| Rebecca Block <blockr@ohsu.edu>
|Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling
| “Symptoms of Depression among Adolescent and Young Adult Latino Men with Cancer”
|Dr. Tania Vu’s  lab in biomedical engineering
|  
|  
|Mac Hall 2201
|--
| <font color=red>9/28/2012</font>
|Guang Fan
|Hematologic Malignancies - Guang Fan, "Highlights of translational research for Hematologic malignancy in Hemepath division"
Carol Beading, “Ion Torrent technology for AML/MDS mutation testing" 
| 
|Mac Hall 2201
|--
|--
| <font color=red>10/7/2011</font>
|10/5/2012
|Brett Sheppard
|Larry Sherman
|Pancreatic Cancer- Setting the Stage
|Mechanisms underlying cognitive disturbances in patients undergoing cancer chemotherapy: A possible intervention
|
|
|   
|Mac Hall 2201  
|--
| <font color=red>10/12/2012</font>
|Tibor Kovacsovics/William Harv Fleming
|Hematologic Malignancies
|
|Mac Hall 2201 
|--
|--
|10/14/2011
|10/19/2012
|Eliot Spindel
|Wei Huang
|Targeting cholinergic signaling in lung cancer
|Quantitative DCE-MRI as a predictor of therapeutic response in acute leukemia
|Dr. Eliot Spindel's lab:  Neuroscience meets lung cancer and lung development
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>10/21/2011</font>  
| <font color=red>10/26/2012</font>  
|Soren Impey
|Jeffrey Tyner/Marc Loriaux
|Pancreas
|Hematologic Malignancies - Jeffrey Tyner: Functional Genomics on Primary Leukemia Specimens to Identify Novel Driver Oncogenes and Therapeutic Strategies
|  
|  
|Mac Hall 2201
|--
|11/2/2012
| Jim Korkola
|
|   
|   
|Mac Hall 2201
|--
|--
|10/28/2011
|11/9/2012
|
| CANCEL - KNIGHT RESEARCH RETREAT
|
|
| 
|Skamania Lodge
|--
| 11/16/2012
|Owen McCarty
|Development of coagulation factor probes for the identification of procoagulant cancer cells
|  
|  
|Mac Hall 2201
|--
|11/23/2012
| CANCEL - THANKSGIVING
|  
|  
|
|
|--
|--
| <font color=red>11/4/2011</font>  
|<font color=red>11/30/2012</font>  
|Philip Streeter
|Brandon Hayes-Lattin/Rebecca Block
|Pancreas: Immunoassays for Detection of Early Pancreatic Cancer
|Hematologic Malignancies
|  
|  
|Mac Hall 2201
|--
|12/7/2012
|Thayer Lab 
|cis-acting elements that control chromosome-wide replication and stability
|  
|  
|Mac Hall 2201
|--
|--
|<font color=red>11/11/2011</font>
|<font color=red>12/14/2012</font>  
|Joe Gray
|
|Pancreas:  “Subtyping pancreatic cancers – advancing diagnosis and treatment”
|Hematologic Malignancies -
|  
|  
|Mac Hall 2201
|--
|12/21/2012
|Charles Keller
|Talk 1:  leptomeningeal metastastis as a cytokine-mediated process;
Talk 2:  Status of the Pediatric Cancer Biology Program
| 
|Mac Hall 2201
|--
| <font color=red>1/4/2013</font>
|Hematologic Malignancies
|
|
| 
|Mac Hall 2201
|--
|--
| <font color=red>11/18/2011</font>  
|<font color=red>1/11/2013</font>  
|Fox Lab
|Hematologic Malignancies
|Pancreas
|
|  
|  
|Mac Hall 2201
|--
|1/18/2012
|Diane Elliot <elliotd@ohsu.edu>
|
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>12/2/2011</font>
|1/25/2013
|Rosie Sears
|Zhi and Wassana
|Pancreas:
|  
|  
|  
|  
|Mac Hall 2201
|--
|--
|12/9/2011
| <font color=red>2/1/2013</font>
|Charles Springer
|Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo?
|  
|  
|
|
|--
| <font color=red>12/16/2011</font>
|
|Pancreas: Brain Storming
|
|  
|  
|Mac Hall 2201
|--
|--
|1/6/2012
|2/8/2013
|CANCELLED
|
|
|
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>1/13/2012</font>  
| <font color=red>2/15/2013</font>  
|
|
|
Steve Chui
Shiuh-Wen Luoh
| Breast Cancer: I-Spy-2 and tissue collection
|
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>1/20/2012</font>
|2/22/2013
|
|
Megan Troxell
| Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions
|  
|
|
| 
|Mac Hall 2201
|--
|--
|1/27/2012
| <font color=red>3/1/2013</font>
|Joshi Alumkal
|
|Thinking Outside the (Androgen) Box in Prostate Cancer
|
|  
|  
|
|Mac Hall 2201
|--
|--
| <font color=red>2/3/2012</font>
|3/8/2013
|
Rosie Sears
 
Jim Korkola
| Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer
|  
|  
|
|
| 
|Mac Hall 2201
|--
|--
|2/10/2012
| <font color=red>3/15/2013</font>
|Steven Jacques
|
|Label-free optical imaging of cellular processes
|  
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>2/17/2012</font>
|3/22/2013
|  
|   
Lisa Coussens
   
| Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy
|
|
|
| 
|Mac Hall 2201
|--
|--
|2/24/2012
|3/29/2013
|George Thomas
|CANCEL - SPRING BREAK
|Re-thinking Targeted Therapies for Kidney Cancer
|
|  
|
|  
|  
|--
|--
| <font color=red>3/2/2012</font>
|4/5/2013
|Juha Rantala
| Mitchell Turker
Koei Chin 
|Chromosome loss, tetraploidy, and aneuploidy
|Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays.
 
Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein
|
|
|
|Mac Hall 2201
|--
|--
|3/9/2012
|<font color=red>4/12/2013</font>
|Daniel Marks
|Brain Mechanisms in Cancer Cachexia
|  
|  
|
|
|
|Mac Hall 2201
|--
|--
| <font color=red>3/16/2012</font>
| 4/19/2013
|Xiangshu Xiao
|
|Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy
|
|  
|  
|Mac Hall 2201
|--
|<font color=red>4/26/2013</font>
|
|
|
|
|Mac Hall 2201
|--
|--
|3/23/2012
| 5/3/2013
|Canceled for the 2012 BioMedicine in 4D Conference
|[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biomedical-engineering/spatial-systems-biomedicine/conference.cfm]
|  
|  
|
|
|
|Mac Hall 2201
|--
|--
| 3/30/2012
| <font color=red>5/10/2013</font>
|NO MEETING
|
| Spring Break
|
|  
|  
|Mac Hall 2201
|--
|5/17/2013
|
|
|
|
|Mac Hall 2201
|--
|--
|<font color=red>4/6/2012</font>
|<font color=red>5/24/2013</font>
| Allen Ebens, PhD
|
| The role of PI3 and PIM kinases in multiple myeloma
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|Mac Hall 2201
|--
|--
|4/13/2012
|5/31/2013
|Jen Vomaske
|
|CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization
|
|<font color=green> ***Note the location change ***
|  
|MAC HALL 2201
|Mac Hall 2201
|--
|--
| <font color=red>4/20/2012</font>  
|<font color=red>6/7/2013</font>
| Zhi Hu
|
 
|
Wassana Yantasee
|
 
|Mac Hall 2201
| Part I. Optimization of therapeutic siRNA against HER2 (Hu)
 
Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee)
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|--
|4/27/2012
|6/14/2013
|Lucia Carbone
|Mechanisms of chromosomal rearrangement in evolution and cancer
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
| <font color=red>5/4/2012</font>
|Joe Gray
 
Paul Spellman
|Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer
 
Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|5/11/2012
|Wong Lab (Nick Smith, Emily Bubbers)
|
|
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
| <font color=red>5/18/2012</font>
| John Muschler
Sunjong Kwon
|Breast Cancer
Sunjong Kwon: Quantitative Imaging of individual mRNAs and co-staining of protein in breast cancer cells
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
| <font color=red>5/25/2012</font>
|Brainstorming - Breast Cancer Focus
|
|
|<font color=green> ***Note the location change ***
|  
|MAC HALL 2201
|Mac Hall 2201
|--
|6/8/2012
|Kinrin Yamanaka (Dr. Stephen Lloyd lab)
|Molecular Targeting of Translesion Synthesis DNA Polymerases for Novel Combination Chemotherapy
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|6/15/2012
|Liskay Lab
|Inhibiting occult clonal expansion of mutant cells as a mechanism of chemoprevention
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|6/22/2012
|Neil Osheroff
|Vanderbilt
|<font color=green> ***Note the location change ***
|MAC HALL 2201

Revision as of 09:29, 27 November 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

  • Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
  • Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
follow the instructions for subscribing
  • We meet in Mac Hall 2201
Fridays 9:00-10:15 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

Jacques Lab, Biomedical Engineering/Dermatology

Gray Lab, OHSU Center for Spacial Systems Biology

  • Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date Presenters Topic Links & Comments Location
9/21/2012 Rebecca Block <blockr@ohsu.edu> “Symptoms of Depression among Adolescent and Young Adult Latino Men with Cancer” Mac Hall 2201
9/28/2012 Guang Fan Hematologic Malignancies - Guang Fan, "Highlights of translational research for Hematologic malignancy in Hemepath division"

Carol Beading, “Ion Torrent technology for AML/MDS mutation testing"

Mac Hall 2201
10/5/2012 Larry Sherman Mechanisms underlying cognitive disturbances in patients undergoing cancer chemotherapy: A possible intervention Mac Hall 2201
10/12/2012 Tibor Kovacsovics/William Harv Fleming Hematologic Malignancies Mac Hall 2201
10/19/2012 Wei Huang Quantitative DCE-MRI as a predictor of therapeutic response in acute leukemia Mac Hall 2201
10/26/2012 Jeffrey Tyner/Marc Loriaux Hematologic Malignancies - Jeffrey Tyner: Functional Genomics on Primary Leukemia Specimens to Identify Novel Driver Oncogenes and Therapeutic Strategies Mac Hall 2201
11/2/2012 Jim Korkola Mac Hall 2201
11/9/2012 CANCEL - KNIGHT RESEARCH RETREAT Skamania Lodge
11/16/2012 Owen McCarty Development of coagulation factor probes for the identification of procoagulant cancer cells Mac Hall 2201
11/23/2012 CANCEL - THANKSGIVING
11/30/2012 Brandon Hayes-Lattin/Rebecca Block Hematologic Malignancies Mac Hall 2201
12/7/2012 Thayer Lab cis-acting elements that control chromosome-wide replication and stability Mac Hall 2201
12/14/2012 Hematologic Malignancies - Mac Hall 2201
12/21/2012 Charles Keller Talk 1: leptomeningeal metastastis as a cytokine-mediated process;

Talk 2: Status of the Pediatric Cancer Biology Program

Mac Hall 2201
1/4/2013 Hematologic Malignancies Mac Hall 2201
1/11/2013 Hematologic Malignancies Mac Hall 2201
1/18/2012 Diane Elliot <elliotd@ohsu.edu> Mac Hall 2201
1/25/2013 Zhi and Wassana Mac Hall 2201
2/1/2013 Mac Hall 2201
2/8/2013 Mac Hall 2201
2/15/2013 Mac Hall 2201
2/22/2013 Mac Hall 2201
3/1/2013 Mac Hall 2201
3/8/2013 Mac Hall 2201
3/15/2013 Mac Hall 2201
3/22/2013 Mac Hall 2201
3/29/2013 CANCEL - SPRING BREAK
4/5/2013 Mitchell Turker Chromosome loss, tetraploidy, and aneuploidy Mac Hall 2201
4/12/2013 Mac Hall 2201
4/19/2013 Mac Hall 2201
4/26/2013 Mac Hall 2201
5/3/2013 Mac Hall 2201
5/10/2013 Mac Hall 2201
5/17/2013 Mac Hall 2201
5/24/2013 Mac Hall 2201
5/31/2013 Mac Hall 2201
6/7/2013 Mac Hall 2201
6/14/2013 Mac Hall 2201
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Research_Group_Meetings&oldid=658971"